Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma

Cham, K. K. Y.; Baker, J. H. E.; Takhar, K. S.; Flexman, J. A.; Wong, M. Q.; Owen, D. A.; Yung, A.; Kozlowski, P.; Reinsberg, S. A.; Chu, E. M.; Chang, C.-W. A.; Buczkowski, A. K.; Chung, S. W.; Scudamore, C. H.; Minchinton, A. I.; Yapp, D. T. T.; Ng, S. S. W.

Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 1(103), p. 52-60, 2010

DOI: 10.1038/sj.bjc.6605727

Tools

Export citation

Search in Google Scholar

Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma

Journal article published in 2010 by K. K. Y. Cham, J. H. E. Baker, K. S. Takhar, J. A. Flexman, M. Q. Wong, D. A. Owen, A. Yung, P. Kozlowski, S. A. Reinsberg

, E. M. Chu, C.-W. A. Chang, A. K. Buczkowski, S. W. Chung, C. H. Scudamore, A. I. Minchinton and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma